An update on the treatment options for gout and calcium pyrophosphate deposition
- 31 October 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 6 (14), 2443-2453
- https://doi.org/10.1517/14656566.6.14.2443
Abstract
Gout and calcium pyrophosphate deposition disease are two common causes of inflammatory joint disease. Despite differences underlying their pathogenesis, their clinical presentation and treatment share some common features. Optimal treatment for both requires prompt resolution of acute synovitis, reduction of chronic joint damage and management of associated conditions. Available therapeutic interventions and future strategies are reviewed in this article.Keywords
This publication has 59 references indexed in Scilit:
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor as a new therapeutic optionAnnals Of The Rheumatic Diseases, 2004
- Toxic epidermal necrolysis-like reaction secondary to colchicine overdoseBritish Journal of Dermatology, 2004
- Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-α-induced apoptosis is mediated by the p38 MAP kinaseCellular Signalling, 2004
- Long-term remission from gout associated with fenofibrate therapyClinical Rheumatology, 2003
- Calcium pyrophosphatase dihydrate (CPPD) crystal deposition disease in a teaching hospital in KuwaitAnnals Of The Rheumatic Diseases, 2001
- Safety of losartan in hypertensive patients with thiazide-induced hyperuricemiaKidney International, 1999
- A Case of Gitelman's Syndrome with Chondrocalcinosis.Endocrine Journal, 1998
- Randomized Double-Blind Comparison of the Analgesic Efficacy of Intramuscular Ketorolac and Oral Indomethacin in the Treatment of Acute Gouty ArthritisAnnals of Emergency Medicine, 1995